Latest filing published 05 Jul 2016 for Ligand Pharmaceuticals INC, €12k.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +83.5%Entry US$33.52 · Close at T+365 US$61.52
- +53.3%Entry US$40.25 · Close at T+365 US$61.72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Melanie J. Herman: trading record in brief
This profile gathers the share dealings of Melanie J. Herman in Ligand Pharmaceuticals Inc. In total, 28 filings cover trades dated from 9 June 2014 to 30 June 2016.
In open-market terms, that means 2 purchases worth €6,964 on one side and 7 sales worth €1.2M on the other. On balance, insiders were net sellers of €1.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants and 12 option exercises. In 2016 alone, the filings show no purchases and 1 sale.
The record was last updated on 5 July 2016 with a transaction (€12k) in Ligand Pharmaceuticals Inc. The most recent open-market purchase was published on 5 January 2015, 4,326 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Melanie J. Herman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 157 shares@ US$87.1025.6% of flowCommon StockSEC:0000886163-16-000196:0
- 334 shares@ US$120.5074.4% of flowCommon StockSEC:0000886163-16-000178:0
- 500 sharesCommon StockSEC:0000886163-16-000142:0
- 160 sharesCommon StockSEC:0000886163-16-000142:1
- 140 sharesCommon StockSEC:0000886163-16-000126:0
- 469 shares@ US$11.15Common StockSEC:0000886163-15-000115:0
- 625 shares@ US$11.91Common StockSEC:0000886163-15-000115:1
- 1,500 shares@ US$14.47Common StockSEC:0000886163-15-000115:2
- 312 shares@ US$21.92Common StockSEC:0000886163-15-000115:3
- 2,500 shares@ US$74.42Common StockSEC:0000886163-15-000115:4
- 625 shares@ US$68.48Common StockSEC:0000886163-15-000115:5
- 1,688 shares@ US$56.26Common StockSEC:0000886163-15-000115:6
- 7,719 shares@ US$101.00Common StockSEC:0000886163-15-000115:7
- 165 shares@ US$45.67Common StockSEC:0000886163-15-000075:0
- 1,500 shares@ US$11.91Common StockSEC:0001209191-15-052410:0
- 875 shares@ US$21.92Common StockSEC:0001209191-15-052410:1
- 1,750 shares@ US$68.48Common StockSEC:0001209191-15-052410:2
- 4,125 shares@ US$93.50Common StockSEC:0001209191-15-052410:3
- 535 shares@ US$60.69Common StockSEC:0000886163-15-000032:0
- 510 shares@ US$57.84Common StockSEC:0000886163-15-000026:0
- 1,200 shares0Common StockSEC:0000886163-15-000023:0
- 103 shares@ US$45.23Common StockSEC:0000886163-15-000006:0Canonical exit: 31 Mar 2015 (T+90)
- 98 shares@ US$43.79Common StockSEC:0000886163-14-000083:0Canonical exit: 28 Sept 2014 (T+90)
- 850 shares@ US$11.91Common StockSEC:0000886163-14-000074:0
- 850 shares@ US$69.68Common StockSEC:0000886163-14-000074:1
25 of 27 declarations
